Abundance Wealth Counselors Has $802,000 Stock Position in UnitedHealth Group Incorporated $UNH

Abundance Wealth Counselors raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% in the 2nd quarter, HoldingsChannel reports. The fund owned 2,572 shares of the healthcare conglomerate’s stock after purchasing an additional 132 shares during the period. Abundance Wealth Counselors’ holdings in UnitedHealth Group were worth $802,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in UNH. Brighton Jones LLC raised its holdings in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC grew its stake in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Apella Capital LLC grew its stake in shares of UnitedHealth Group by 44.1% in the 1st quarter. Apella Capital LLC now owns 1,682 shares of the healthcare conglomerate’s stock valued at $973,000 after purchasing an additional 515 shares during the period. Nixon Peabody Trust Co. grew its stake in shares of UnitedHealth Group by 34.0% in the 1st quarter. Nixon Peabody Trust Co. now owns 536 shares of the healthcare conglomerate’s stock valued at $281,000 after purchasing an additional 136 shares during the period. Finally, Johnson & White Wealth Management LLC grew its stake in shares of UnitedHealth Group by 1.5% in the 1st quarter. Johnson & White Wealth Management LLC now owns 1,798 shares of the healthcare conglomerate’s stock valued at $942,000 after purchasing an additional 26 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.4%

Shares of UNH opened at $353.26 on Friday. The firm has a market capitalization of $319.94 billion, a price-to-earnings ratio of 15.31, a PEG ratio of 2.27 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The business’s fifty day moving average price is $306.25 and its two-hundred day moving average price is $356.57. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

Analysts Set New Price Targets

Several research firms have recently weighed in on UNH. Robert W. Baird reiterated an “underperform” rating and issued a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Barclays increased their price target on UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Baird R W lowered UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Oppenheimer decreased their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Finally, Royal Bank Of Canada decreased their price target on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.